Skip to main content
Premium Trial:

Request an Annual Quote

Predictive Protein Test Sounds Better Than Personal Genome Service Anyway

San Francisco Bay Area-based Tethys Bioscience has received another round of cash on the order of tens of millions, putting their total funding to date at $54 million, says a Wired article. Their test will use protein biomarkers to determine whether someone will become diabetic way before standard diagnostic tests reveal the condition. Instead of relying on genetic markers, Tethys says "using biomarkers like proteins in the blood might provide an even better way than examining genes to answer a patient's most pressing question: Will I get sick?," says the article.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.